QT Imaging (NASDAQ:QTI – Get Free Report) and electroCore (NASDAQ:ECOR – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, analyst recommendations, institutional ownership, dividends, profitability, earnings and risk.
Volatility and Risk
QT Imaging has a beta of -0.1, indicating that its share price is 110% less volatile than the S&P 500. Comparatively, electroCore has a beta of 0.56, indicating that its share price is 44% less volatile than the S&P 500.
Profitability
This table compares QT Imaging and electroCore’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
QT Imaging | N/A | N/A | -65.94% |
electroCore | -54.40% | -154.45% | -69.16% |
Institutional and Insider Ownership
Valuation & Earnings
This table compares QT Imaging and electroCore”s revenue, earnings per share (EPS) and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
QT Imaging | N/A | N/A | -$4.03 million | N/A | N/A |
electroCore | $16.03 million | 4.05 | -$18.83 million | ($1.83) | -5.42 |
QT Imaging has higher earnings, but lower revenue than electroCore.
Analyst Recommendations
This is a summary of current ratings and recommmendations for QT Imaging and electroCore, as reported by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
QT Imaging | 0 | 0 | 0 | 0 | 0.00 |
electroCore | 0 | 0 | 1 | 0 | 3.00 |
About QT Imaging
QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems for detection, diagnosis, monitoring, and treatment of diseases. The company offers QT Ultrasound Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient’s breast. QT Imaging Holdings, Inc. was founded in 2011 and is based in Novato, California.
About electroCore
electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
Receive News & Ratings for QT Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for QT Imaging and related companies with MarketBeat.com's FREE daily email newsletter.